Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC. (AGN)

40
Delayed Quote. Delayed Nyse - 10/24 04:00:32 pm
184.21 USD   +0.46%
1d ago ALLERGAN : Announces Quarterly Conference Call
4d ago Stronger oil stocks and surge in Shire lift FTSE
4d ago ALLERGAN : Valeant may up Allergan offer
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on ALLERGAN, INC.
1d ago ALLERGAN : Announces Quarterly Conference Call
3d ago ALLERGAN : Patent Issued for Variable Cohesive Gel Form-Stable Breast Implant
3d ago ALLERGAN : Patent Issued for Compositions Containing Alpha-2-Adrenergic Agonist ..
3d ago ALLERGAN : Patent Issued for Interior Needle Stick Guard Stems for Tubes
3d ago ALLERGAN : Patent Issued for Biological Tissue Growth through Induced Tensile St..
3d ago ALLERGAN : Harvard Business Review Ranks David Pyott One of the Top 5 CEOs in th..
4d ago JOHN PAULSON : John Paulson's Solution To Shire Problem Probably Not Sitting Wel..
4d ago Stronger oil stocks and surge in Shire lift FTSE
4d ago ALLERGAN : Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredi..
4d ago ALLERGAN : Valeant may up Allergan offer
4d ago Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredit Valean..
5d ago WILLIAM ACKMAN : Ackman, Valeant lawyers say Allergan CEO oversaw campaign to di..
5d ago TSX advances with gold miners, Valeant
5d ago Top Allergan holder Paulson urges deal with Shire - sources
5d ago TOP ALLERGAN HOLDER PAULSON URGES DE : sources
5d ago Valeant says may raise Allergan bid; beats on profit
5d ago Valeant CEO sees revised Allergan bid worth more than $200 per share
5d ago Valeant may raise Allergan bid, says it won't walk away
5d agoDJU.S. HOT STOCKS : Hot Stocks to Watch
5d ago ALLERGAN : Other Events, Financial Statements and Exhibits (form 8-K)
5d ago ALLERGAN : David Pyott Recognized by Harvard Business Review
10/16 ACKMAN : Lawyers have documents purported to show Allergan misled on Valeant
10/16 AbbVie board ditches planned $55 billion Shire acquisition
10/15 ALLERGAN : Patent Issued for Ester Pro-Drugs of Methanol for Treating Retinal Di..
10/15 ALLERGAN : Patent Issued for Polysaccharide Gel Formulation Having Increased Lon..
10/15 ALLERGAN : Harvard Business Review Ranks David Pyott One of the Top 5 CEOs in th..
10/14 Irish tax changes may cost U.S. groups billions
10/14 ALLERGAN : Dr. Rami Batniji Selected By Allergan To Test Their Total Facial Reju..
10/14 ALLERGAN : Offers Details of Earnings Per Share and Sales Expectations
10/13 ALLERGAN : Pershing Square debuts on Euronext Amsterdam
10/13 Activist investor Ackman's fund Pershing dips on Amsterdam debut
10/10 EXCLUSIVE - TOP ACTAVIS HOLDER, FIDE : sources
10/09 Allergan raises outlook; says Valeant offer undervalues company
10/09 ALLERGAN : Results of Operations and Financial Condition, Financial Statements a..
10/09 ALLERGAN : Provides Update on Earnings Per Share and Sales Expectations
10/09DJU.S. HOT STOCKS : Hot Stocks to Watch
10/08 ALLERGAN : Patent Issued for Targeted Delivery of Botulinum Toxin to the Sphenop..
10/08 ALLERGAN : Announces FDA Approves Revised Indication for OZURDEX® dexamethasone ..
10/08 ALLERGAN : Actavis plans Allergan offer
10/07 EXCLUSIVE : Actavis plans new merger approach for Allergan - sources
10/07 EXCLUSIVE - ACTAVIS PLANS NEW MERGER : sources
10/04 ALLERGAN : Assigned Patent
10/03 ALLERGAN : Researchers Submit Patent Application, "Composition of a Sustained-Re..
10/03 ALLERGAN : Researchers Submit Patent Application, "Prostanoid Receptor Agonist C..
10/03 ALLERGAN : Patent Application Titled "Compositions Including Encapsulated Isotre..
10/03 ALLERGAN : "Prostamides for Enhancement of Leptin Production" in Patent Applicat..
10/03 ALLERGAN : Researchers Submit Patent Application, "Inhibition of Neovascularizat..
10/03 ALLERGAN : Researchers Submit Patent Application, "Inhibition of Neovascularizat..
10/02 ALLERGAN : Assigned Patent
10/01 ALLERGAN : Ackman's Pershing Square raises $3 bln in fund listing
09/29 ALLERGAN : Valeant Pharmaceuticals' third-quarter sales to rise
09/29 ALLERGAN : Other Events, Financial Statements and Exhibits (form 8-K)
09/29 ALLERGAN : Announces FDA Approves Revised Indication for OZURDEX® (dexamethasone..
09/29 ALLERGAN : Board of Directors Issues Statement
09/28 ALLERGAN : Plastic Surgery Practice in Naples Awarded Allergan's Diamond Status
09/25 TSX tumbles to three-month low as sentiment sours
09/25 ALLERGAN : Issues Statement Regarding Recent Valeant Correspondence
09/25 ALLERGAN : Valeant pitches potential eye drug, research focus
09/24 ALLERGAN : Pershing Square, Valeant and Allergan Settle Pending Litigation Befor..
09/24 ALLERGAN : "Ophthalmic Compositions and Methods for Treating Eyes" in Patent App..
09/24 ALLERGAN : Patent Issued for Computer Analysis of a Breast Shape to Assist Breas..
09/24 ALLERGAN : to Hold Special Meeting of Stockholders on Originally Scheduled Date ..
09/24 ALLERGAN : Patent Issued for Compounds Having Analgesic And/Or Immunostimulant A..
09/24 ALLERGAN : Patent Application Titled "Preservative Free Bimatoprost and Timolol ..
09/24 ALLERGAN : Actress And TV Star Kyle Richards Diagnosed With A Type Of Chronic Dr..
09/24 S&P 500 MOVERS : Btu, bbby
09/24 ALLERGAN : Valeant Pharma expects 3Q revenue to top forecasts
09/24 Valeant CEO expects quarterly profit to exceed forecast
09/24 ACTAVIS IN BUYOUT TALKS WITH SALIX : Cnbc
09/24 ALLERGAN : Valeant Provides Update On Third Quarter Results And Sends Letter To ..
09/24 ALLERGAN : Assigned Patent
09/23 ALLERGAN : Write-Offs: 09.22.14
09/18 ALLERGAN : Actress And Tv Star Kyle Richards Diagnosed With A Type Of Chronic Dr..
09/18 ALLERGAN : to cut its workforce by 13%
09/18 ALLERGAN : Assigned Patent
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF